Potent antiplatelet therapy increases bleeding risk after heart attack in AF patients
Potent antiplatelet therapy increased bleeding without signs of benefit regarding cardiovascular events in patients with atrial fibrillation after…
Comparative study finds higher rates of adverse events with ticagrelor
One year of treatment with either of two strong blood-thinning medications—ticagrelor and prasugrel—by people with type 1 or…